Mouse orthotopic models for bladder cancer research

BJU International

Volumn 104, Issue 9, 2009, Pages 1286-1291

  Chan, Eddie ^a   Patel, Amit ^a   Heston, Warren ^a   Larchian, William ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Bladder cancer; Imaging; Mouse model; Orthotopic

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTOFLUORESCENCE; BLADDER CANCER; CANCER CELL CULTURE; CANCER DIAGNOSIS; CANCER GROWTH; CANCER RECURRENCE; CANCER RESEARCH; CONTROLLED STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; RELIABILITY; REPRODUCIBILITY; TUMOR GROWTH; UROGENITAL TRACT CANCER; XENOGRAFT;

ANIMALS; CELL LINE, TUMOR; DIAGNOSTIC IMAGING; DISEASE MODELS, ANIMAL; HUMANS; MICE; NEOPLASM TRANSPLANTATION; TRANSPLANTATION, HETEROLOGOUS; URINARY BLADDER NEOPLASMS;

EID: 70349972532     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2009.08577.x     Document Type: Article

References (44)

1. Maxwell Parkin D. The global burden of urinary bladder cancer. Scand J Urol Nephrol 2008 26 : 1 9
2. Burgues JP, Gomez L, Pontones JL, Vera CD, Jimenez-Cruz JF, Ozonas M. A chemosensitivity test for superficial bladder cancer based on three-dimensional culture of tumour spheroids. Eur Urol 2007 51 : 962 969
3. Xiao Z, McCallum TJ, Brown KM et al. Characterization of a novel transplantable orthotopic rat bladder transitional cell tumour model. Br J Cancer 1999 81 : 638 646
4. Grippo PJ, Sandgren EP. Highly invasive transitional cell carcinoma of the bladder in a simian virus 40 T-antigen transgenic mouse model. Am J Pathol 2000 157 : 805 813
5. Mo L, Zheng X, Huang HY et al. Hyperactivation of Ha-ras oncogene, but not Ink4a/Arf deficiency, triggers bladder tumorigenesis. J Clin Invest 2007 117 : 314 325
6. Donehower LA. The p53-deficient mouse: a model for basic and applied cancer studies. Semin Cancer Biol 1996 7 : 269 278
7. Zhang ZT, Pak J, Shapiro E, Sun TT, Wu XR. Urothelium-specific expression of an oncogene in transgenic mice induced the formation of carcinoma in situ and invasive transitional cell carcinoma. Cancer Res 1999 59 : 3512 3517
8. Soloway MS. Intravesical and systemic chemotherapy of murine bladder cancer. Cancer Res 1977 37 : 2918 2929
9. Summerhayes IC, Franks LM. Effects of donor age on neoplastic transformation of adult mouse bladder epithelium in vitro. J Natl Cancer Inst 1979 62 : 1017 1023
10. Larchian WA, Horiguchi Y, Nair SK, Fair WR, Heston WD, Gilboa E. Effectiveness of combined interleukin 2 and B7.1 vaccination strategy is dependent on the sequence and order: a liposome-mediated gene therapy treatment for bladder cancer. Clin Cancer Res 2000 6 : 2913 2920
11. Horinaga M, Harsch KM, Fukuyama R, Heston W, Larchian W. Intravesical interleukin-12 gene therapy in an orthotopic bladder cancer model. Urology 2005 66 : 461 466
12. Liu H, Schwartz MJ, Hwang DH, Scherr DS. Tumour growth inhibition by an imidazoquinoline is associated with c-Myc down-regulation in urothelial cell carcinoma. BJU Int 2008 101 : 894 901
13. Kohno S, Luo C, Goshima F, Nishiyama Y, Sata T, Ono Y. Herpes simplex virus type 1 mutant HF10 oncolytic viral therapy for bladder cancer. Urology 2005 66 : 1116 1121
14. Nativ O, Dalal E, Hidas G, Aronson M. EDTA-induced urothelial cell shedding for the treatment of superficial bladder cancer in the mouse. Int J Urol 2006 13 : 1344 1346
15. Cheon J, Moon DG, Cho HY et al. Adenovirus-mediated suicide-gene therapy in an orthotopic murine bladder tumor model. Int J Urol 2002 9 : 261 267
16. Sindhwani P, Hampton JA, Baig MM, Keck R, Selman SH. Curcumin prevents intravesical tumor implantation of the MBT-2 tumor cell line in C3H mice. J Urol 2001 166 : 1498 1501
17. Smith EB, Schwartz M, Kawamoto H et al. Antitumor effects of imidazoquinolines in urothelial cell carcinoma of the bladder. J Urol 2007 177 : 2347 2351
18. Watanabe T, Shinohara N, Sazawa A et al. An improved intravesical model using human bladder cancer cell lines to optimize gene and other therapies. Cancer Gene Ther 2000 7 : 1575 1580
19. Yu DS, Lee CF, Chang SY. Immunotherapy for orthotopic murine bladder cancer using bacillus Calmette-Guerin recombinant protein Mpt-64. J Urol 2007 177 : 738 742
20. Takahashi T, Kushiro A, Nomoto K et al. Antitumor effects of the intravesical instillation of heat killed cells of the Lactobacillus casei strain Shirota on the murine orthotopic bladder tumor MBT-2. J Urol 2001 166 : 2506 2511
21. Mangsbo SM, Ninalga C, Essand M, Loskog A, Totterman TH. CpG therapy is superior to BCG in an orthotopic bladder cancer model and generates CD4+ T-cell immunity. J Immunother 2008 31 : 34 42
22. Jurczok A, Fornara P, Soling A. Bioluminescence imaging to monitor bladder cancer cell adhesion in vivo: a new approach to optimize a syngeneic, orthotopic, murine bladder cancer model. BJU Int 2008 101 : 120 124
23. Bohle A, Jurczok A, Ardelt P et al. Inhibition of bladder carcinoma cell adhesion by oligopeptide combinations in vitro and in vivo. J Urol 2002 167 : 357 363
24. Shapiro A, Kelley DR, Oakley DM, Catalona WJ, Ratliff TL. Technical factors affecting the reproducibility of intravesical mouse bladder tumor implantation during therapy with Bacillus Calmette-Guerin. Cancer Res 1984 44 : 3051 3054
25. Hadaschik BA, Black PC, Sea JC et al. A validated mouse model for orthotopic bladder cancer using transurethral tumour inoculation and bioluminescence imaging. BJU Int 2007 100 : 1377 1384
26. Chang SG, Kim JI, Jung JC et al. Antimetastatic activity of the new platinum analog [Part (cis-dach) (DPPE).2NO3] in a metastatic model of human bladder cancer. Anticancer Res 1997 17 : 3239 3242
27. Jiang F, Zhou XM. A model of orthotopic murine bladder (MBT-2) tumor implants. Urol Res 1997 25 : 179 182
28. Werthman PE, Drazan KE, Rosenthal JT, Khalili R, Shaked A. Adenoviral-p53 gene transfer to orthotopic and peritoneal murine bladder cancer. J Urol 1996 155 : 753 756
29. Soloway MS, Masters S. Urothelial susceptibility to tumor cell implantation: influence of cauterization. Cancer 1980 46 : 1158 1163
30. Gunther JH, Jurczok A, Wulf T et al. Optimizing syngeneic orthotopic murine bladder cancer (MB49). Cancer Res 1999 59 : 2834 2837
31. Ahlering TE, Dubeau L, Jones PA. A new in vivo model to study invasion and metastasis of human bladder carcinoma. Cancer Res 1987 47 : 6660 6665
32. Soloway MS, Nissenkorn I, McCallum L. Urothelial susceptibility to tumor cell implantation: comparison of cauterization with N-methyl-N-nitrosourea. Urology 1983 21 : 159 61
33. Weldon TE, Soloway MS. Susceptibility of urothelium to neoplastic cellular implantation. Urology 1975 5 : 824 827
34. Chin J, Kadhim S, Garcia B, Kim YS, Karlik S. Magnetic resonance imaging for detecting and treatment monitoring of orthotopic murine bladder tumor implants. J Urol 1991 145 : 1297 1301
35. Chong L, Ruping Y, Jiancheng B et al. Characterization of a novel transplantable orthotopic murine xenograft model of a human bladder transitional cell tumor (BIU-87). Cancer Biol Ther 2006 5 : 394 398
36. Chade DC, Andrade PM, Borra RC et al. Histopathological characterization of a syngeneic orthotopic murine bladder cancer model. Int Braz J Urol 2008 34 : 220 229
37. Lyons SK. Advances in imaging mouse tumour models in vivo. J Pathol 2005 205 : 194 205
38. Chin JL, Kadhim SA, Batislam E et al. Mycobacterium cell wall: an alternative to intravesical bacillus Calmette Guerin (BCG) therapy in orthotopic murine bladder cancer. J Urol 1996 156 : 1189 93
39. Kikuchi E, Xu S, Ohori M et al. Detection and quantitative analysis of early stage orthotopic murine bladder tumor using in vivo magnetic resonance imaging. J Urol 2003 170 : 1375 1378
40. Henriquez NV, van Overveld PG, Que I et al. Advances in optical imaging and novel model systems for cancer metastasis research. Clin Exp Metastasis 2007 24 : 699 705
41. Satoh H, Morimoto Y, Arai T et al. Intravesical ultrasonography for tumor staging in an orthotopically implanted rat model of bladder cancer. J Urol 2007 177 : 1169 1173
42. Patel AR, Larchian WA, Heston WD. Micro-ultrasound imaging for bladder cancer in a murine model. J Urol 2008 179 (Suppl. 368
43. Goertz DE, Yu JL, Kerbel RS, Burns PN, Foster FS. High-frequency Doppler ultrasound monitors the effects of antivascular therapy on tumor blood flow. Cancer Res 2002 62 : 6371 6375
44. Lyshchik A, Fleischer AC, Huamani J, Hallahan DE, Brissova M, Gore JC. Molecular imaging of vascular endothelial growth factor receptor 2 expression using targeted contrast-enhanced high-frequency ultrasonography. J Ultrasound Med 2007 26 : 1575 1586